Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection carries
a substantial risk of severe and prolonged illness; treatment options are currently limited. …

Background The 2009 pandemic influenza A (H1N1) virus has emerged to cause the first
pandemic of the 21st century. Development of effective vaccines is a public health priority. …

Background Antibiotic overuse in respiratory illness is common and is associated with drug
resistance and hospital-acquired infection. Biomarkers that can identify bacterial infections …

Background Respiratory virus infection is a common cause of hospitalisation in adults. Rapid
point-of-care testing (POCT) for respiratory viruses might improve clinical care by reducing …

Background The management of the COVID-19 pandemic is hampered by long delays
associated with centralised laboratory PCR testing. In hospitals, these delays lead to poor patient …

In the past few weeks, there has been a great deal of trepidation among the public about the
impact of children returning to school on the transmission of severe acute respiratory …

Objectives The effect of SARS-CoV-2 on existing respiratory viruses in circulation and the
overall burden of viral respiratory disease remains uncertain. Traditionally, severe viral …

Objectives The clinical impact of rapid sample-to-answer “syndromic” multiplex polymerase
chain reaction (PCR) testing for respiratory viruses is not clearly established. We performed …

Objectives Many adult patients hospitalised with acute respiratory illness have viruses
detected but the overall importance of viral infection compared to bacterial infection is unclear. …

Both viruses and bacteria are thought to cause exacerbations of chronic obstructive
pulmonary disease (COPD); however, the relative importance of each remains uncertain. C-reactive …